In the recent study, Polyphen-2, when compared with SIFT, M-CAP and CADD tools, can make better pathogenicity predictions for familial hypercholesterolemia (FH) causative LDLRAP1 mutations (24). This evidence concerns the gene LDLRAP1 and familial hyperaldosteronism.